Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: British Journal of Cancer, 79, 7-8, S. 1182-1184
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg, Springer Science and Business Media LLC
- (wann)
-
1999
- Urheber
-
Wittke, F.
Hoffmann, Reinhard
Buer, J.
Dallmann, I.
Oevermann, K.
Sel, S.
Wandert, T.
Ganser, A.
Atzpodien, J.
- DOI
-
10.1038/sj.bjc.6690189
- URN
-
urn:nbn:de:bvb:384-opus4-782380
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:55 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wittke, F.
- Hoffmann, Reinhard
- Buer, J.
- Dallmann, I.
- Oevermann, K.
- Sel, S.
- Wandert, T.
- Ganser, A.
- Atzpodien, J.
- Universität Augsburg, Springer Science and Business Media LLC
Entstanden
- 1999
Ähnliche Objekte (12)
Psychosocial Variables Associated with Immunosuppressive Medication Non-Adherence after Renal Transplantation
Capecitabine in the treatment of metastatic renal cell carcinoma
Individualization of the Immunosuppressive Therapy in Patients of Renal Transplantations through Pharmacodynamic and Pharmacogenetic Biomarkers
Characterization of the immunosuppressive tumour microenvironment in a mouse model of clear cell renal cell carcinoma
Immunosuppressive Leberfaktoren : experimentelle Studien
Regional differences in clear cell metastatic renal cell carcinoma patients across the USA
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma
Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma
Molecular determinants of therapy response in metastatic clear cell renal cell carcinoma (MORE study)
Treatment Algorithm for Metastatic Renal Cell Carcinoma – Recommendations Based on Evidence and Clinical Practice
Early detection of the immunophenotyping after conversion to belatacept in comparison to conventional immunosuppressive therapy in renal transplant patients
Psychosocial Variables Associated with Immunosuppressive Medication Non-Adherence after Renal Transplantation
Capecitabine in the treatment of metastatic renal cell carcinoma
Individualization of the Immunosuppressive Therapy in Patients of Renal Transplantations through Pharmacodynamic and Pharmacogenetic Biomarkers
Characterization of the immunosuppressive tumour microenvironment in a mouse model of clear cell renal cell carcinoma
Immunosuppressive Leberfaktoren : experimentelle Studien
Regional differences in clear cell metastatic renal cell carcinoma patients across the USA
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma
Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma
Molecular determinants of therapy response in metastatic clear cell renal cell carcinoma (MORE study)
Treatment Algorithm for Metastatic Renal Cell Carcinoma – Recommendations Based on Evidence and Clinical Practice
Early detection of the immunophenotyping after conversion to belatacept in comparison to conventional immunosuppressive therapy in renal transplant patients
Psychosocial Variables Associated with Immunosuppressive Medication Non-Adherence after Renal Transplantation
Capecitabine in the treatment of metastatic renal cell carcinoma
Individualization of the Immunosuppressive Therapy in Patients of Renal Transplantations through Pharmacodynamic and Pharmacogenetic Biomarkers
Characterization of the immunosuppressive tumour microenvironment in a mouse model of clear cell renal cell carcinoma
Immunosuppressive Leberfaktoren : experimentelle Studien
Regional differences in clear cell metastatic renal cell carcinoma patients across the USA
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma
Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma
Molecular determinants of therapy response in metastatic clear cell renal cell carcinoma (MORE study)
Treatment Algorithm for Metastatic Renal Cell Carcinoma – Recommendations Based on Evidence and Clinical Practice